@article{JTD22290,
author = {Alessio Cortellini and Antonella Dal Mas and Katia Cannita and Guido Collina and Alessandro Parisi and Francesco Pavese and Giampiero Porzio and Lucilla Verna and Corrado Ficorella},
title = {Where are we with treatment options after first line in small cell lung cancer?—report of two opposite cases treated with CAPTEM regimen and possible perspectives},
journal = {Journal of Thoracic Disease},
volume = {10},
number = {7},
year = {2018},
keywords = {},
abstract = {With platinum-etoposide doublets, oncologists have long been used to “play it safe” in first line setting of extensive disease small cell lung cancer (ed-SCLC) patients. Instead second line treatment was historically considered a stumbling block, hard to handle both for patients and clinicians, where all the expectations are quickly disappointed.},
issn = {2077-6624}, url = {https://jtd.amegroups.org/article/view/22290}
}